By ECONOMICTIMES.COM | Apr 22,
2017, 03.00 PM IST
Specific
batches of 60 drugs have failed quality tests in sample-based screening of
Central Drugs Standard Control Organisation (CDSCO), the national drug
regulatory agency, in March. These include painkiller Combiflam, anti-cold D
Cold Total, anti-allergic Cetrizine, and drugs containing antibiotics ciprofloxacin
and ofloxacin.
The batches of 60 drugs find mention in CDSCO's
March safety bulletin which describes these drugs as "not of Standard
Quality/Spurious/Adulterated/Misbranded.
Both
the batches of Combiflam and D-Cold tablets failed the test because of
"disintegration" issues. Reason of failure for Cetrizine was
"related substances". Ofloxacine and ciprofloxacine failed
"assay" which is a quantitative tests for ingredients. A gentamicine
injection failed the test for "particulate matter". Pantoprazole
failed the test for "dissolution".
A list
of these drugs and their problems is available on the CDSCO website .
Read more at:
http://economictimes.indiatimes.com/articleshow/58311729.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
No comments:
Post a Comment